Mannkind (MNKD) Enterprise Value (2010 - 2026)
Mannkind (MNKD) posted quarterly Enterprise Value of -$134.6 million for Q1 2026, up 26.15% year-over-year from -$106.7 million in Q1 2025, and up 21.78% quarter-over-quarter from -$172.1 million in Q4 2025.
Mannkind (MNKD) Enterprise Value (2010 - 2026) Analysis & Trends
Mannkind (MNKD) has reported Enterprise Value for 17 consecutive years, with -$134.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Enterprise Value rose 26.15% year-over-year to -$134.6 million; the TTM figure through Mar 2026 stood at -$134.6 million (up 26.15% YoY), while the FY2025 annual figure was -$172.1 million, up 13.08% from the prior year.
- Enterprise Value advanced to -$134.6 million in Q1 2026 per MNKD's latest filing, from -$172.1 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$134.6 million in Q1 2026 and bottomed at -$300.7 million in Q1 2024.
- Historically, Enterprise Value has averaged -$195.8 million across 5 years, with a median of -$172.1 million in 2025.
- Annual changes were most pronounced in 2022 — Enterprise Value jumped 41.33% — and 2024, when it sank 81.01%.
- Mannkind's Enterprise Value stood at -$170.8 million in 2022, then plunged by 72.73% to -$295.1 million in 2023, then surged by 32.91% to -$198.0 million in 2024, then advanced by 13.08% to -$172.1 million in 2025, then advanced by 21.78% to -$134.6 million in 2026.
- Business Quant data shows MNKD's Enterprise Value at -$134.6 million in Q1 2026, -$172.1 million in Q4 2025, and -$260.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | Mannkind | 1.19 Bn | 1.08 Bn | 94.97 Mn | -111.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -111.88 Mn |
| Mar 31, 2026 | -134.61 Mn |
| Dec 31, 2025 | -172.09 Mn |
| Sep 30, 2025 | -260.78 Mn |
| Jun 30, 2025 | -179.73 Mn |
| Mar 31, 2025 | -182.28 Mn |
| Dec 31, 2024 | -197.99 Mn |
| Sep 30, 2024 | -252.32 Mn |
| Jun 30, 2024 | -248.49 Mn |
| Mar 31, 2024 | -300.73 Mn |
| Dec 31, 2023 | -295.10 Mn |
| Sep 30, 2023 | -141.02 Mn |
| Jun 30, 2023 | -144.35 Mn |
| Mar 31, 2023 | -166.14 Mn |
| Dec 31, 2022 | -170.85 Mn |
| Sep 30, 2022 | -165.04 Mn |
| Jun 30, 2022 | -154.16 Mn |
| Mar 31, 2022 | -162.40 Mn |
| Dec 31, 2021 | -204.12 Mn |
| Sep 30, 2021 | -139.05 Mn |